Results 231 to 240 of about 81,306 (284)

A whole genomic CRISPR-Cas9 screen identifies the amino acid transporter SLC43A1 (LAT3) as a major determinant of oxaliplatin sensitivity in colorectal cancer cells. [PDF]

Mol Cancer Ther
Pawar NR, Wade HM, Jackson Z, Poungpeth N, Mitchell AV, Jewell CP, Chan D, Batista PJ, Robey RW, Jenkins LM, Gottesman MM.   +10 more
europepmc   +1 more source

Pattern‐Based P53 Immunohistochemistry Predicts Recurrence in Colorectal Liver Metastases Without Complete Pathologic Response After Neoadjuvant Chemotherapy

Cancer Reports, Volume 9, Issue 10, October 2026.
ABSTRACT Background Aberrant p53 expression may have prognostic significance in colorectal cancer; however, its role in patients with colorectal liver metastases (CRLM) who receive neoadjuvant chemotherapy but do not achieve pathological complete response (pCR) remains unclear.
Phat Thi Hong Ho, Duy Duc Nguyen, Vuong Dinh Thy Hao, Giang Huong Tran, Lam Viet Trung, Thinh Van Hoang, Hoang Bac Nguyen   +6 more
wiley   +1 more source

NCX2 Targeting as a Neuroprotective Strategy Against Oxaliplatin-Induced Peripheral Neurotoxicity. [PDF]

Cancers (Basel)
Di Girolamo S, Invernizzi C, Kraus MF, Ballarini E, Malacrida A, Mauri M, Rodriguez-Menendez V, Housley SN, Alberti P.   +8 more
europepmc   +1 more source

Case Report: Exchange transfusion for hemolytic anemia and acute kidney injury associated with hepatic arterial infusion chemotherapy with raltitrexed and oxaliplatin in a patient with hepatocellular carcinoma. [PDF]

Front Med (Lausanne)
Zhang C, Yan Y, Li X, Dong Y.
europepmc   +1 more source

Second-line oxaliplatin reintroduction or paclitaxel-ramucirumab in metastatic gastroesophageal cancer: a population-based study. [PDF]

Ther Adv Med Oncol
Siegerink SN, Kuijper SC, van den Ende T, Verhoeven RHA, Elias SG, Mohammad NH, Slingerland M, Derks S, van Laarhoven HWM.   +8 more
europepmc   +1 more source

Association between voltage-gated sodium channel gene polymorphisms and chronic oxaliplatin-induced peripheral neuropathy in Japanese patients with colorectal cancer. [PDF]

J Pharm Health Care Sci
Matsuura M, Nagamine A, Masuno T, Tabei A, Nasaka T, Nishiba H, Koike M, Takahashi Y, Obayashi K.   +8 more
europepmc   +1 more source

Gemcitabine plus Nivolumab with Carboplatin or Oxaliplatin in Cisplatin-Ineligible Patients with Metastatic Urothelial Carcinoma: A Randomized Phase II Trial. [PDF]

Clin Cancer Res
Li Z, Izadmehr S, Hoffman-Censits J, Maughan B, Mayer T, Tan A, Brody R, Xie H, Nie K, Kelly G, Ioannou G, Cabal R, Tuballes K, Guo R, Figueiredo I, Del Valle DM, Mehrazin R, Yu M, Zhao Q, Kim-Schulze S, Sfakianos JP, Gupta S, Hahn NM, Gonzalez-Kozlova E, Gnjatic S, Galsky MD.   +25 more
europepmc   +1 more source

An oral berberine nanocapsule platform orchestrates microbiota for potent gastric cancer chemotherapy. [PDF]

J Nanobiotechnology
Gong S, Zhang Y, Du W, Zhang C, Wu N, Zhang X, Ren Z, Zhang Y, Zhang P, Zhan C, Wu X.   +10 more
europepmc   +1 more source